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Abstract 
    The mechanism for homeostatic sleep/wake regulation and the neural substrate for 
“sleepiness” remain among the biggest mysteries in sleep biology. To make a breakthrough in this 
issue, our laboratory has initiated a large-scale forward genetic screen of sleep/wake abnormalities 
in mice based on somnographic (electroencephalography (EEG)/electromyography (EMG)) 
measurements, which are the gold standard in mammalian sleep/wake assessment. We have so far 
screened > 8,000 heterozygous ENU-mutagenized mice and established multiple pedigrees 
exhibiting heritable and specific sleep/wake abnormalities. By combining linkage analysis and 
whole-exome sequencing, we have identified two dominant mutations that strongly affect 
sleep/wakefulness (Funato H, Honda T, Yanagisawa M et al., Nature 2016). A splicing mutation in 
the Sik3 protein kinase gene (termed Sleepy mutation) causes marked hypersomnia (i.e., increased 
non-REM sleep (NREMS)) due to an increase in inherent sleep need. A missense mutation in the 
sodium leak channel NALCN (termed Dreamless mutation) reduces both the total amount and 
episode duration of REM sleep, apparently by increasing the excitability of REM sleep-inhibiting 
neurons. Since these dominant mutations cause severe and specific sleep abnormalities, we expect 
that the mutated genes play central roles in regulating sleep/wake amounts.  
 
    To elucidate the molecular basis of how the Sik3 gene is involved in sleep/wake regulation, 
we performed genetic and biochemical analyses. SIK3 has a serine-threonine kinase domain at the 
N terminus and a protein kinase A (PKA) recognition site (Ser551) in the middle portion. The 
skipping of exon 13 resulted in an in-frame deletion of 52 amino acids (ΔEx13, termed Sleepy 
mutation) encompassing Ser551, a PKA recognition site. Thus, we hypothesized that Ser551 of Sik3 
has an essential role for the regulation of daily sleep amount and sleep need. To examine this 
hypothesis, we generated the transgenic mice with Ser551Ala substitution (termed S551A mutant) 
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and Ser551Asp substitution (termed S551D mutant) by CRISPR/Cas9 system.  
 
    As a result, S551A and S551D mutant mice both exhibited longer NREMS and decreased 
wakefulness, similar to the phenotype of the exon skipped Sleepy (ΔEx13) mutant. Moreover, both 
S551A and S551D mutant mice exhibited increased density of slow-wave activity during NREMS 
and increased individual NREMS episode durations, suggesting that the baseline sleep need is 
inherently increased in the mutants. To elucidate the mechanism of their sleep/wake phenotypes 
with prolonged NREMS, we performed biochemical analyses by using a series of expression 
plasmids (WT, Sleepy (ΔEx13), S551A, S551D) to examine how the mutations at Ser551 affect the 
signaling pathway and binding partners of SIK3. Through immunoprecipitation and western 
blotting, we confirmed that in Sleepy (ΔEx13), S551A, and S551D, all the mutants showed decreased 
binding to phospho-PKA substrate antibody. This result strongly suggests that the SIK3 protein with 
the mutations S551A, S551D and Sleepy (ΔEx13) is excluded from the possible substrates of PKA. 
Together, these three mutants showed abolished bindings toward 14-3-3, which corresponded to 
their consistent hypersomnia phenotypes with prolonged NREMS.  
 
   These results suggest that the existence of Ser551 in the Sik3 gene and its signaling pathway, 
including PKA and 14-3-3, may play a key role in sleep/wake regulation under normal physiological 
conditions. Notably, the exon 13-encoded region of Sik3, including Ser551, is highly conserved 
among both vertebrates and invertebrates, which suggests the biological importance of the 
phosphorylation pathway PKA / SIK3 / 14-3-3 in sleep/wake regulation. These findings provide 
landmark information about the novel sleep/wake regulatory mechanisms by connecting the 
intracellular signaling pathway to the dynamic in vivo sleep/wake behaviors. 
 
